org-26576
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2007 (NCT00610649)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Glutamate receptor ionotropic AMPAPOSITIVE ALLOSTERIC MODULATOR
Glutamate receptor ionotropic AMPA positive allosteric modulator
Ampakine molecule.
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3707401 ↗
Also known as
- mk-8777
- mk-8777
- org-26576
- org-26576
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00610441 | Phase 2 | Apr 1, 2008 | Merck |
| NCT00610649 | Phase 2 | Sep 1, 2007 | Merck |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Merck | For profit | 2 | 2 | 1 | 2007 |
1 organizations
Page 1 / 1